Clinical and Virologic Response to HHV-8 Associated Multicentric Castleman's Disease to Valganciclovir.
Latest Information Update: 20 Apr 2017
At a glance
- Drugs Valganciclovir (Primary)
- Indications Giant lymph node hyperplasia
- Focus Therapeutic Use
- 23 Jun 2009 Planned end date (May 2009) added as reported by ClinicalTrials.gov.
- 09 Feb 2009 Planned number of patients changed from 64 to 8 as reported by ClinicalTrials.gov.
- 09 Feb 2009 Actual initiation date (Dec 2008) added as reported by ClinicalTrials.gov.